1 Min Read
* Says it received a patent for Quinoline Derivatives As Smo Inhibitors in Canada, with valid of 20 years
Source text in Chinese: goo.gl/h6574J
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.